The Lancet The Lancet, Elsevier, 2019, 394 (10204), pp.1169-1180. ⟨10.1016/S0140-6736(19)31887-2⟩ The Lancet (London), 394, 1169-1180 Bhatt, D L, Steg, P G, Mehta, S R, Leiter, L A, Simon, T, Fox, K, Held, C, Andersson, M, Himmelmann, A, Ridderstråle, W, Chen, J, Song, Y, Diaz, R, Goto, S, James, S K, Ray, K K, Parkhomenko, A N, Kosiborod, M N, McGuire, D K, Harrington, R A & THEMIS Steering Committee and Investigators 2019, ' Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI) : a phase 3, placebo-controlled, randomised trial ', Lancet, vol. 394, no. 10204, pp. 1169-1180 . https://doi.org/10.1016/S0140-6736(19)31887-2 The Lancet (London), 394, 10204, pp. 1169-1180
The Lancet The Lancet, Elsevier, 2018, 391 (10117), pp.219-229. ⟨10.1016/S0140-6736(17)32409-1⟩ Anand, S S, Bosch, J, Eikelboom, J W, Connolly, S J, Diaz, R, Widimsky, P, Aboyans, V, Alings, M, Kakkar, A K, Keltai, K, Maggioni, A P, Lewis, B S, Störk, S, Zhu, J, Lopez-Jaramillo, P, O'Donnell, M, Commerford, P J, Vinereanu, D, Pogosova, N, Ryden, L, Fox, K A A, Bhatt, D L, Misselwitz, F, Varigos, J D, Vanassche, T, Avezum, A A, Chen, E, Branch, K, Leong, D P, Bangdiwala, S I, Hart, R G, Yusuf, S & COMPASS Investigators 2018, ' Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease : an international, randomised, double-blind, placebo-controlled trial ', Lancet, vol. 391, no. 10117, pp. 219-229 . https://doi.org/10.1016/S0140-6736(17)32409-1 Anand, S S, Bosch, J, Eikelboom, J W, Connolly, S J, Diaz, R, Widimsky, P, Aboyans, V, Alings, M, Kakkar, A K, Keltai, K, Maggioni, A P, Lewis, B S, Störk, S, Zhu, J, Lopez-Jaramillo, P, O'Donnell, M, Commerford, P J, Vinereanu, D, Pogosova, N, Ryden, L, Fox, K A A, Bhatt, D L, Misselwitz, F, Varigos, J D, Vanassche, T, Avezum, A A, Chen, E, Branch, K, Leong, D P, Bangdiwala, S I, Hart, R G, Yusuf, S, COMPASS Investigators & Houlind, K C 2018, ' Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease : an international, randomised, double-blind, placebo-controlled trial ', Lancet, vol. 391, no. 10117, pp. 219-229 . https://doi.org/10.1016/S0140-6736(17)32409-1
Connolly, S J, Eikelboom, J W, Bosch, J, Dagenais, G, Dyal, L, Lanas, F, Metsarinne, K, O'Donnell, M, Dans, A L, Ha, J-W, Parkhomenko, A N, Avezum, A A, Lonn, E, Lisheng, L, Torp-Pedersen, C, Widimsky, P, Maggioni, A P, Felix, C, Keltai, K, Hori, M, Yusoff, K, Guzik, T J, Bhatt, D L, Branch, K R H, Cook Bruns, N, Berkowitz, S D, Anand, S S, Varigos, J D, Fox, K A A, Yusuf, S & COMPASS investigators 2018, ' Rivaroxaban with or without aspirin in patients with stable coronary artery disease : an international, randomised, double-blind, placebo-controlled trial ', The Lancet, vol. 391, no. 10117, pp. 205-218 . https://doi.org/10.1016/S0140-6736(17)32458-3 Connolly, S J, Eikelboom, J W, Bosch, J, Dagenais, G, Dyal, L, Lanas, F, Metsarinne, K, O'Donnell, M, Dans, A L, Ha, J-W, Parkhomenko, A N, Avezum, A A, Lonn, E, Lisheng, L, Torp-Pedersen, C, Widimsky, P, Maggioni, A P, Felix, C, Keltai, K, Hori, M, Yusoff, K, Guzik, T J, Bhatt, D L, Branch, K R H, Cook Bruns, N, Berkowitz, S D, Anand, S S, Varigos, J D, Fox, K A A, Yusuf, S & COMPASS Investigators 2018, ' Rivaroxaban with or without aspirin in patients with stable coronary artery disease : an international, randomised, double-blind, placebo-controlled trial ', Lancet, vol. 391, no. 10117, pp. 205-218 . https://doi.org/10.1016/S0140-6736(17)32458-3 BASE-Bielefeld Academic Search Engine Connolly, S J, Eikelboom, J W, Bosch, J, Dagenais, G, Dyal, L, Lanas, F, Metsarinne, K, O'Donnell, M, Dans, A L, Ha, J-W, Parkhomenko, A N, Avezum, A A, Lonn, E, Lisheng, L, Torp-Pedersen, C, Widimsky, P, Maggioni, A P, Felix, C, Keltai, K, Hori, M, Yusoff, K, Guzik, T J, Bhatt, D L, Branch, K R H, Cook Bruns, N, Berkowitz, S D, Anand, S S, Varigos, J D, Fox, K A A, Yusuf, S, COMPASS Investigators & Houlind, K C 2018, ' Rivaroxaban with or without aspirin in patients with stable coronary artery disease : an international, randomised, double-blind, placebo-controlled trial ', Lancet, vol. 391, no. 10117, pp. 205-218 . https://doi.org/10.1016/S0140-6736(17)32458-3